Literature DB >> 6144710

Lactoferrin acts on I-A and I-E/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulatory factors in vitro.

H E Broxmeyer, E Platzer.   

Abstract

The relationship between Ia antigens on mouse resident peritoneal macrophages and the ability of lactoferrin (LF) to inhibit the production of granulocyte-macrophage colony stimulatory factors (GM-CSF) from these cells was investigated. Detection of the suppressive influence of LF on release of GM-CSF from greater than or equal to 10(5) macrophages/ml/plate required that the conditioned media being assessed for GM-CSF be prepared in the presence of indomethacin and/or be preincubated with anti-ferritin antiserum to respectively stop production of E-type prostaglandins and to remove acidic isoferritin-inhibitory activities that can mask the effects of LF. Treatment of mouse macrophages with monoclonal antibodies to the I-A and I-E/C subregions of Ia antigens in a complement C-dependent cytotoxicity assay killed less than 15% of the cells, but removed all Ia antigen+ macrophages and reduced GM-CSF production by approximately 50%. LF decreased GM-CSF production by untreated macrophages by approximately 50%, but had no effect on macrophages insensitive to treatment with anti-Ia plus C. Macrophages left at 37 degrees C for 5 and 24 hr were not killed by treatment with monoclonal anti-Ia plus C and GM-CSF production by these macrophages was not suppressed by LF. Treatment of macrophages with monoclonal anti-H-2K or anti-Mac-1 plus C reduced GM-CSF production greater than 95%. Anti-I-A, -I-E/C, -H-2K, or -Mac-1, in the absence of C, had no effect on viability of macrophages or on production of GM-CSF, but anti-I-A and -I-E/C each blocked the inhibitory action of LF. Lower concentrations of these antibodies could block the action of LF when anti-I-A and anti-I-E/C were mixed together better than when they were each used separately. The removal of Thy-1.2+ cells from unseparated or adherent peritoneal cells resulted in populations of cells that were up to 100% positive for nonspecific esterase, and did not influence GM-CSF production from these cells, the reduction of GM-CSF from these cells by LF, or the reduction of GM-CSF by the removal of Ia antigen+ cells. The results were similar whether or not T cells were removed from the assay marrow by treatment with antibodies Ly-1.1, Ly-2.2, and Qa4 plus C.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6144710

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  CD1d expression on and regulation of murine hematopoietic stem and progenitor cells.

Authors:  Hal E Broxmeyer; Kent Christopherson; Giao Hangoc; Scott Cooper; Charlie Mantel; Gourapura J Renukaradhya; Randy R Brutkiewicz
Journal:  Blood       Date:  2012-04-25       Impact factor: 22.113

2.  Differential staining of neutrophils and monocytes: surface and cytoplasmic iron-binding proteins.

Authors:  J C Barton; R T Parmley; T W Butler; S E Williamson; M B Lilly; R J Gualtieri; L W Heck
Journal:  Histochem J       Date:  1988-03

3.  Bovine lactoferrin binding to six species of coagulase-negative staphylococci isolated from bovine intramammary infections.

Authors:  A S Naidu; J Miedzobrodzki; M Andersson; L E Nilsson; A Forsgren; J L Watts
Journal:  J Clin Microbiol       Date:  1990-10       Impact factor: 5.948

4.  Characterization of binding of human lactoferrin to pneumococcal surface protein A.

Authors:  A Håkansson; H Roche; S Mirza; L S McDaniel; A Brooks-Walter; D E Briles
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Antibacterial activity in bovine lactoferrin-derived peptides.

Authors:  K S Hoek; J M Milne; P A Grieve; D A Dionysius; R Smith
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Synergistic myelopoietic actions in vivo after administration to mice of combinations of purified natural murine colony-stimulating factor 1, recombinant murine interleukin 3, and recombinant murine granulocyte/macrophage colony-stimulating factor.

Authors:  H E Broxmeyer; D E Williams; G Hangoc; S Cooper; S Gillis; R K Shadduck; D C Bicknell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

Review 7.  The Immunology of Mammary Gland of Dairy Ruminants between Healthy and Inflammatory Conditions.

Authors:  Mohamed Ezzat Alnakip; Marcos Quintela-Baluja; Karola Böhme; Inmaculada Fernández-No; Sonia Caamaño-Antelo; Pillar Calo-Mata; Jorge Barros-Velázquez
Journal:  J Vet Med       Date:  2014-11-10

8.  Isolation and characterization of resident stromal macrophages and hematopoietic cell clusters from mouse bone marrow.

Authors:  P R Crocker; S Gordon
Journal:  J Exp Med       Date:  1985-09-01       Impact factor: 14.307

9.  Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon.

Authors:  G Degliantoni; M Murphy; M Kobayashi; M K Francis; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1985-11-01       Impact factor: 14.307

10.  Inhibition of bone marrow colony formation by human natural killer cells and by natural killer cell-derived colony-inhibiting activity.

Authors:  G Degliantoni; B Perussia; L Mangoni; G Trinchieri
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.